Gil Shklarski

Gil is a Scientific Co-Founder at Neuralight.ai, building an AI-driven platform that will digitize neurological evaluation and care.

Before Neuralight, Gil served as CTO of Flatiron Health from its inception through its acquisition by Roche in 2018. He grew the technology team to 350 people across software, devops, IT, security, product design, and data science before exiting in 2021.

Prior to Flatiron, Gil built web-scale data processing systems at Facebook and Microsoft supporting content, users, and systems safety.

​

Before coming to the U.S., Gil developed high-performance, mission-critical systems as a researcher, consultant and R&D group manager in elite technology units within Israel’s Ministry of Defense.

​

As an angel investor, Gil has invested in multiple technology startups in the US and Israel, including Cardless, Nym Health, Laika, Assured Allies, RightBound, and Immuta.

​

Gil holds a PhD in computer science in the field of scientific computing from Tel-Aviv University. Gil will never say no to geeking out on anything technology.